Nath Bio Genes India Profit & Loss Annual

BSE: 537291 | NSE: NATHBIOGEN | ISIN: INE448G01010 | Sector: Crops

182.25 +8.50 (4.89%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	332.62	301.36	278.36	307.56
Total Revenue	332.62	301.36	278.36	307.56
Costof Revenue Total	133.57	105.52	115.19	126.03
Gross Profit	199.05	195.85	163.17	181.53
Selling/ General/ Admin Expenses Total	121.25	35.30	60.54	58.10
Depreciation/ Amortization	3.26	3.01	3.08	2.82
Unusual Expense( Income)	0.00	0.00	88.78	-
Other Operating Expenses Total	27.31	102.43	56.52	47.44
Total Operating Expense	285.40	255.63	332.99	243.54
Operating Income	47.23	45.73	-54.63	64.02
Interest Inc( Exp) Net- Non- Op Total	-91.11	-89.81	-89.74	-68.12
Other Net	0.00	-0.59	0.21	-0.48
Net Income Before Taxes	38.12	36.16	-63.39	56.75
Provisionfor Income Taxes	1.95	1.15	3.95	1.09
Net Income After Taxes	36.17	35.01	-67.34	55.66
Net Income Before Extra Items	36.17	35.01	-67.34	55.66
Total Extraordinary Items	3.45	-	-	-
Net Income	39.62	35.01	-67.34	55.66
Income Availableto Com Excl Extra Ord	36.17	35.01	-67.34	55.66
Income Availableto Com Incl Extra Ord	39.62	35.01	-67.34	55.66
Dilution Adjustment	-34.49	-	-	-
Diluted Net Income	36.17	35.01	-67.34	55.66
Diluted Weighted Average Shares	1.69	1.90	1.90	1.90
Diluted EPS Excluding Extra Ord Items	19.31	18.42	-35.43	29.29
DPS- Common Stock Primary Issue	2.00	2.00	2.00	2.00
Diluted Normalized EPS	19.31	18.42	-5.07	29.28
Research Development	-	93.71	88.85	91.54
Gain( Loss)on Saleof Assets	-	-0.01	0.04	0.18
Total Adjustmentsto Net Income	-	-	0.04	-